Pasithea Therapeutics (KTTA) Interest & Investment Income (2022 - 2026)
Pasithea Therapeutics (KTTA) recorded Interest & Investment Income of $410,416 in Q2 2026, up 654.1% from $54,424 a year earlier but down 8.9% from the prior quarter.
Powered by 
Analysis
Pasithea Therapeutics (KTTA) Interest & Investment Income (2022 - 2026) Analysis & Trends
On a TTM basis, Pasithea Therapeutics' Interest & Investment Income came in at $1.09 million as of Jun 30, 2026, up 322.3% year-over-year; for FY2025, it was $327,193, down 22.7% from FY2024.
- Across earlier years, Interest & Investment Income came in at $423,184 in FY2024 (+1.9%) and $415,368 in FY2023.
- Quarterly Interest & Investment Income has ranged from -$335,317 in Q3 2022 to $450,338 in Q1 2026 over the past five years.
- On a year-over-year basis, Interest & Investment Income has increased for three consecutive quarters, with growth averaging 171.7% over the last eight quarters.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 853.2% in Q1 2026, against a decline of 69.2% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $450,338 (Q1 2026), $182,128 (Q4 2025) and $43,396 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Pasithea Therapeutics | 16.04 Mn | 16.04 Mn | - | 410,416.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 410,416.00 |
| Mar 31, 2026 | 450,338.00 |
| Dec 31, 2025 | 182,128.00 |
| Sep 30, 2025 | 43,396.00 |
| Jun 30, 2025 | 54,424.00 |
| Mar 31, 2025 | 47,245.00 |
| Dec 31, 2024 | 80,483.00 |
| Sep 30, 2024 | 75,076.00 |
| Jun 30, 2024 | 114,407.00 |
| Mar 31, 2024 | 153,218.00 |
| Dec 31, 2023 | 172,825.00 |
| Sep 30, 2023 | 131,740.00 |
| Sep 30, 2022 | -335,317.00 |
API Access
Pasithea Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KTTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "KTTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KTTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();